Showing 141 - 160 results of 100,903 for search '(( 10 ns decrease ) OR ( 5 ((ng decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.42s Refine Results
  1. 141

    mFIZZ1′ and mFIZZ1 decreased the IL-13 and IL-5 secretion of splenocytes. by Wael Gad (285901)

    Published 2013
    “…(<b>A</b>) Recombinant mFIZZ1′ and mFIZZ1 co-expressed with hQSOX1b significantly decreased the IL-5 secretion compared to the proteins expressed alone. …”
  2. 142
  3. 143

    Inhibition of PI4KIIIα by AL-9 induces the formation of large NS5A clusters. by Annalisa Bianco (178719)

    Published 2012
    “…Zoomed sections are indicated by a yellow square. Long incubation with AL-9 (8–16 hours) results in increased NS5A clustering and concomitantly a decrease of PI4P in the internal membranes.…”
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148
  9. 149
  10. 150
  11. 151

    Virus replication is decreased by treatment of HDAC inhibitors. by Angelika Danielsson (229695)

    Published 2011
    “…<p>LNCaP and PC-346C were transduced with Ad[i/PPT-E1A, E3] and Ad5 wt and BON cells were transduced with Ad[CgA-E1A] and Ad5 wt. …”
  12. 152
  13. 153

    NS5A regulates PC expression level. by Seung-Ae Yim (430539)

    Published 2013
    “…<p>(A–C) PC expression level is decreased, whereas FAS expression level is increased in cells expressing NS5A protein. …”
  14. 154

    L-sel decreases the number of circulating lymphocytes. by Izabela Rozenberg (214521)

    Published 2011
    “…<b>F</b>) The number of activated T-cells (CD4<sup>+</sup>CD44<sup>+</sup>) remained unchanged after 6 weeks of HCD (n = 5–7; p = n.s.) and decreased after 12 weeks of HCD (n = 5–7; <sup>*</sup>p<0.05) as compared to control.…”
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”